Trial intelligence / Profile preview

Preoperative intravenous tranexamic acid to reduce blood loss in difficult benign hysterectomy

TCTR20250206001Phase 3Completed

Sponsor
Khon Kaen Hospital
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Benign uterine conditions comparing Tranexamic acid with Placebo (2 arms). Started Sep 2024; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Benign uterine conditions

Beyond the preview

Go deeper on TCTR20250206001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250206001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call